Yook, S.; Cai, Z.; Jeong, J. J.; Lu, Y.; Winnik, M. A.; Pignol, J. - P.; Reilly, R. M. A Dual Receptor-Targeted (Drt) Radiation Nanomedicine Labeled With 177Lu Is More Potent For Killing Human Breast Cancer Cells In Vitro That Co-Express Her2 And Egfr Than Single Receptor-Targeted (Srt) Radiation Nanomedicines. Mol. Pharmaceutics 2020, 17, 1226?1236.

Cai, Z.; Yook, S.; Lu, Y.; Bergstrom, D.; Winnik, M. A.; Pignol, J. - P.; Reilly, R. M. Local Radiation Treatment Of Her2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled With 177Lu. Pharmaceutical Research 2017, 34, 579?590.

Lai, P.; Cai, Z.; Pignol, J. - P.; Lechtman, E.; Mashouf, S.; Lu, Y.; Winnik, M. A.; Jaffray, D. A.; Reilly, R. M. Onte Carlo Simulation Of Radiation Transport And Dose Deposition From Locally Released Gold Nanoparticles Labeled With 111In, 177Lu Or 90Y Incorporated Into Tissue Implantable Depots. Physics in Medicine and Biology 2017, 62, 8581?8599.